Common allergy drug tested to help Parkinson's patients

NCT ID NCT06785298

Recruiting now Disease control Sponsor: Tanta University Source: ClinicalTrials.gov ↗

Summary

This study is testing whether adding the allergy medication fexofenadine to standard Parkinson's treatment can improve patients' quality of life. The trial involves 46 adults aged 50+ who are already taking dopamine replacement therapy for Parkinson's. Researchers will measure changes using standard Parkinson's rating scales to see if the combination treatment provides additional benefit.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Tanta University
RECRUITING

Tanta, 31511, Egypt

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

PARKINSON DISEASE